| Dr James S Elliott, MD | |
|
2900 12th Ave N, Suite 140w, Billings, MT 59101-7506 | |
| (406) 238-6540 | |
| (406) 238-6599 |
| Full Name | Dr James S Elliott |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 37 Years |
| Location | 2900 12th Ave N, Billings, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235121849 | NPI | - | NPPES |
| 101153 | Medicaid | MT | |
| 200015690 | Other | MT | RAILROAD MEDICARE |
| 000091748 | Other | MT | BLUECROSS BLUESHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 7371 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Vincent Healthcare | Billings, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ortho Montana, Psc | 5193627404 | 33 |
News Archive
The Institute for Systems Biology (ISB) and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington's disease (HD). ISB has engaged Complete Genomics to sequence 100 genomes, the majority of which will be used to investigate this disease, with samples from affected individuals, family members, and matched controls to study modifiers of disease presentation and progression.
The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion's platforms open up whole new avenues for compound safety testing.
...says Dutch researcher Bas Tomassen. He investigated the uptake and secretion of water by the plasma membrane of animal and human cells.
Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA (adalimumab) for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis (UC) when certain other medicines have not worked well enough.
A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.
› Verified 2 days ago
| Entity Name | Ortho Montana, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174515878 PECOS PAC ID: 5193627404 Enrollment ID: O20040126000480 |
News Archive
The Institute for Systems Biology (ISB) and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington's disease (HD). ISB has engaged Complete Genomics to sequence 100 genomes, the majority of which will be used to investigate this disease, with samples from affected individuals, family members, and matched controls to study modifiers of disease presentation and progression.
The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion's platforms open up whole new avenues for compound safety testing.
...says Dutch researcher Bas Tomassen. He investigated the uptake and secretion of water by the plasma membrane of animal and human cells.
Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA (adalimumab) for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis (UC) when certain other medicines have not worked well enough.
A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James S Elliott, MD 2900 12th Ave N, Suite 140w, Billings, MT 59101-7506 Ph: (406) 238-6540 | Dr James S Elliott, MD 2900 12th Ave N, Suite 140w, Billings, MT 59101-7506 Ph: (406) 238-6540 |
News Archive
The Institute for Systems Biology (ISB) and Complete Genomics Inc. announced today that they are embarking on a large-scale human genome sequencing study of Huntington's disease (HD). ISB has engaged Complete Genomics to sequence 100 genomes, the majority of which will be used to investigate this disease, with samples from affected individuals, family members, and matched controls to study modifiers of disease presentation and progression.
The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion's platforms open up whole new avenues for compound safety testing.
...says Dutch researcher Bas Tomassen. He investigated the uptake and secretion of water by the plasma membrane of animal and human cells.
Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA (adalimumab) for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis (UC) when certain other medicines have not worked well enough.
A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.
› Verified 2 days ago
Michael C. Willis, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2702 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Michael Thompson Groover, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N Ste 140w, Billings, MT 59101 Phone: 406-237-5050 Fax: 406-238-6599 | |
David W Shenton Jr., M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2900 12th Ave N, #100e, Billings, MT 59101 Phone: 406-238-6700 Fax: 406-238-6734 | |
Lindsey J Beck, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N Ste 140w, Billings, MT 59101 Phone: 406-237-5050 Fax: 406-238-6599 | |
Charles Trevor Crellin, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N Ste 140w, Billings, MT 59101 Phone: 406-237-5050 Fax: 406-272-3395 | |
Ralph M Costanzo, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2900 12th Ave N, #100e, Billings, MT 59101 Phone: 406-238-6700 Fax: 406-238-6734 | |
Bryon D Hobby, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2702 8th Ave N, Billings, MT 59101 Phone: 406-238-5200 |